info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Helicobacter Pylori (H. Pylori) Test Market Research Report Information, By Test Type (Non-endoscopic, and Endoscopic), By Technology (Immunoassays, Point of care, and Molecular Diagnostics) And, By End-User (Hospitals & clinics, Diagnostic laboratories, and Others), By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032


ID: MRFR/HC/7025-HCR | 90 Pages | Author: Kinjoll Dey| December 2024

Market Segmentation


H. Pylori (Helicobacter Pylori) Test Test Type Outlook (USD Billion, 2018-2032)




  • Non-endoscopic




  • Endoscopic




H. Pylori (Helicobacter Pylori) Test Technology Outlook (USD Billion, 2018-2032)




  • Immunoassays




  • Point of care




  • Molecular Diagnostics




H. Pylori (Helicobacter Pylori) Test End user Outlook (USD Billion, 2018-2032)




  • Hospitals & clinics




  • Diagnostic laboratories




  • Others




H. Pylori (Helicobacter Pylori) Test Regional Outlook (USD Billion, 2018-2032)




  • North America Outlook (USD Billion, 2018-2032)




    • North America H. Pylori (Helicobacter Pylori) Test by Test Type




      • Non-endoscopic




      • Endoscopic






    • North America H. Pylori (Helicobacter Pylori) Test by Technology




      • Immunoassays




      • Point of care




      • Molecular Diagnostics






    • North America H. Pylori (Helicobacter Pylori) Test by End user




      • Hospitals & clinics




      • Diagnostic laboratories




      • Others






    • US Outlook (USD Billion, 2018-2032)




    • US H. Pylori (Helicobacter Pylori) Test by Test Type




      • Non-endoscopic




      • Endoscopic






    • US H. Pylori (Helicobacter Pylori) Test by Technology




      • Immunoassays




      • Point of care




      • Molecular Diagnostics






    • US H. Pylori (Helicobacter Pylori) Test by End user




      • Hospitals & clinics




      • Diagnostic laboratories




      • Others






    • CANADA Outlook (USD Billion, 2018-2032)




    • CANADA H. Pylori (Helicobacter Pylori) Test by Test Type




      • Non-endoscopic




      • Endoscopic






    • CANADA H. Pylori (Helicobacter Pylori) Test by Technology




      • Immunoassays




      • Point of care




      • Molecular Diagnostics






    • CANADA H. Pylori (Helicobacter Pylori) Test by End user




      • Hospitals & clinics




      • Diagnostic laboratories




      • Others








  • Europe Outlook (USD Billion, 2018-2032)




    • Europe H. Pylori (Helicobacter Pylori) Test by Test Type




      • Non-endoscopic




      • Endoscopic






    • Europe H. Pylori (Helicobacter Pylori) Test by Technology




      • Immunoassays




      • Point of care




      •  






    • Europe H. Pylori (Helicobacter Pylori) Test by End user




      • Hospitals & clinics




      • Diagnostic laboratories






    • Germany Outlook (USD Billion, 2018-2032)




    • Germany H. Pylori (Helicobacter Pylori) Test by Test Type




      • Non-endoscopic




      • Endoscopic




      • Neroli




      • Lavender




      • Others






    • Germany H. Pylori (Helicobacter Pylori) Test by Technology




      • Immunoassays




      • Point of care






    • Germany H. Pylori (Helicobacter Pylori) Test by End-user




      • Hospitals & clinics




      • Diagnostic laboratories






    • France Outlook (USD Billion, 2018-2032)




    • France H. Pylori (Helicobacter Pylori) Test by Test Type




      • Non-endoscopic




      • Endoscopic






    • France H. Pylori (Helicobacter Pylori) Test by Technology




      • Immunoassays




      • Point of care




      • Molecular Diagnostics






    • France H. Pylori (Helicobacter Pylori) Test by End user




      • Hospitals & clinics




      • Diagnostic laboratories




      • Others






    • UK Outlook (USD Billion, 2018-2032)




    • UK H. Pylori (Helicobacter Pylori) Test by Test Type




      • Non-endoscopic




      • Endoscopic






    • UK H. Pylori (Helicobacter Pylori) Test by Technology




      • Immunoassays




      • Point of Care




      • Molecular Diagnostics






    • UK H. Pylori (Helicobacter Pylori) Test by End user




      • Hospitals & clinics




      • Diagnostic laboratories




      • Others






    • ITALY Outlook (USD Billion, 2018-2032)




    • ITALY H. Pylori (Helicobacter Pylori) Test by Test Type




      • Non-endoscopic




      • Endoscopic






    • ITALY H. Pylori (Helicobacter Pylori) Test by Technology




      • Immunoassays




      • Point of care




      • Molecular Diagnostics






    • ITALY H. Pylori (Helicobacter Pylori) Test by End user




      • Hospitals & clinics




      • Diagnostic laboratories




      • Others






    • SPAIN Outlook (USD Billion, 2018-2032)




    • Spain H. Pylori (Helicobacter Pylori) Test by Test Type




      • Non-endoscopic




      • Endoscopic






    • Spain H. Pylori (Helicobacter Pylori) Test by Technology




      • Immunoassays




      • Point of care




      • Molecular Diagnostics






    • Spain H. Pylori (Helicobacter Pylori) Test by End-user




      • Hospitals & clinics




      • Diagnostic laboratories




      • Others






    • Rest Of Europe Outlook (USD Billion, 2018-2032)




    • Rest Of Europe H. Pylori (Helicobacter Pylori) Test by , Test Type




      • Non-endoscopic




      • Endoscopic






    • REST OF EUROPE H. Pylori (Helicobacter Pylori) Test by Technology




      • Immunoassays




      • Point of care




      • Molecular Diagnostics






    • REST OF EUROPE H. Pylori (Helicobacter Pylori) Test by End user




      • Hospitals & clinics




      • Diagnostic laboratories




      • Others








  • Asia-Pacific Outlook (USD Billion, 2018-2032)




    • Asia-Pacific H. Pylori (Helicobacter Pylori) Test by Test Type




      • Non-endoscopic




      • Endoscopic




      • Molecular Diagnostics






    • Asia-Pacific H. Pylori (Helicobacter Pylori) Test by Technology




      • Immunoassays




      • Point of care




      • Molecular Diagnostics






    • Asia-Pacific H. Pylori (Helicobacter Pylori) Test by End user




      • Hospitals & clinics




      • Diagnostic laboratories




      • Others






    • China Outlook (USD Billion, 2018-2032)




    • China H. Pylori (Helicobacter Pylori) Test by Test Type




      • Non-endoscopic




      • Endoscopic






    • China H. Pylori (Helicobacter Pylori) Test by Technology




      • Immunoassays




      • Point of care




      • Molecular Diagnostics






    • China H. Pylori (Helicobacter Pylori) Test by End-user




      • Hospitals & clinics




      • Diagnostic laboratories




      • Others






    • Japan Outlook (USD Billion, 2018-2032)




    • Japan H. Pylori (Helicobacter Pylori) Test by Test Type




      • Non-endoscopic




      • Endoscopic






    • Japan H. Pylori (Helicobacter Pylori) Test by Technology




      • Immunoassays




      • Point of care




      • Molecular Diagnostics






    • Japan H. Pylori (Helicobacter Pylori) Test by End-user




      • Hospitals & clinics




      • Diagnostic laboratories




      • Others






    • India Outlook (USD Billion, 2018-2032)




    • India H. Pylori (Helicobacter Pylori) Test by Test Type




      • Non-endoscopic




      • Endoscopic






    • India H. Pylori (Helicobacter Pylori) Test by Technology




      • Immunoassays




      • Point of care




      • Molecular Diagnostics






    • India H. Pylori (Helicobacter Pylori) Test by End user




      • Hospitals & clinics




      • Diagnostic laboratories




      • Others






    • Australia Outlook (USD Billion, 2018-2032)




    • Australia H. Pylori (Helicobacter Pylori) Test by Test Type




      • Non-endoscopic




      • Endoscopic






    • Australia H. Pylori (Helicobacter Pylori) Test by Technology




      • Immunoassays




      • Point of care




      • Molecular Diagnostics






    • Australia H. Pylori (Helicobacter Pylori) Test by End user




      • Hospitals & clinics




      • Diagnostic laboratories




      • Others






    • Rest of Asia-Pacific Outlook (USD Billion, 2018-2032)




    • Rest of Asia-Pacific H. Pylori (Helicobacter Pylori) Test by Test Type




      • Non-endoscopic




      • Endoscopic






    • Rest of Asia-Pacific H. Pylori (Helicobacter Pylori) Test by Technology




      • Immunoassays




      • Point of care




      • Molecular Diagnostics






    • Rest of Asia-Pacific H. Pylori (Helicobacter Pylori) Test by End user




      • Hospitals & clinics




      • Diagnostic laboratories




      • Others








  • Rest of the World Outlook (USD Billion, 2018-2032)




    • Rest of the World H. Pylori (Helicobacter Pylori) Test by Test Type




      • Non-endoscopic




      • Endoscopic






    • Rest of the World H. Pylori (Helicobacter Pylori) Test by Technology




      • Immunoassays




      • Point of care




      • Molecular Diagnostics






    • Rest of the World H. Pylori (Helicobacter Pylori) Test by End-user




      • Hospitals & clinics




      • Diagnostic laboratories




      • Others






    • Middle East Outlook (USD Billion, 2018-2032)




    • Middle East H. Pylori (Helicobacter Pylori) Test by Test Type




      • Non-endoscopic




      • Endoscopic






    • Middle East H. Pylori (Helicobacter Pylori) Test by Technology




      • Immunoassays




      • Point of care




      • Molecular Diagnostics






    • Middle East H. Pylori (Helicobacter Pylori) Test by End user




      • Hospitals & clinics




      • Diagnostic laboratories




      • Others






    • Africa Outlook (USD Billion, 2018-2032)




    • Africa H. Pylori (Helicobacter Pylori) Test by Test Type




      • Non-endoscopic




      • Endoscopic






    • Africa H. Pylori (Helicobacter Pylori) Test by Technology




      • Immunoassays




      • Point of care




      • Molecular Diagnostics






    • Africa H. Pylori (Helicobacter Pylori) Test by End user




      • Hospitals & clinics




      • Diagnostic laboratories




      • Others






    • Latin America Outlook (USD Billion, 2018-2032)




    • Latin America H. Pylori (Helicobacter Pylori) Test by Test Type




      • Non-endoscopic




      • Endoscopic






    • Latin America H. Pylori (Helicobacter Pylori) Test by Technology




      • Immunoassays




      • Point of care




      • Molecular Diagnostics






    • Latin America H. Pylori (Helicobacter Pylori) Test by End user




      • Hospitals & clinics




      • Diagnostic laboratories




      • Others







Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Please fill in Business Email for Quick Response

Table of Contents

1. EXECUTIVE SUMMARY

1.1. Market Attractiveness Analysis

1.1.1. Global H. Pylori Test Market, by Test Type

1.1.2. Global H. Pylori Test Market, by Technology

1.1.3. Global H. Pylori Test Market, by End User

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.5. Breakdown of Primary Respondents

3.6. Forecasting Techniques

3.7. Research Methodology for Market Size Estimation

3.8. Bottom-Up Approach

3.9. Top-Down Approach

3.10. Data Triangulation

3.11. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Porter’s Five Forces Analysis

5.1.1. Bargaining Power of Suppliers

5.1.2. Bargaining Power of Buyers

5.1.3. Threat of New Entrants

5.1.4. Threat of Substitutes

5.1.5. Intensity of Rivalry

5.2. Value Chain Analysis

5.2.1. R&D and Designing

5.2.2. Manufacturing

5.2.3. Distribution & Sales

5.2.4. Post Sales Services

6. GLOBAL H. PYLORI TEST MARKET, BY TEST TYPE

6.1. Overview

6.2. Non-Endoscopic

6.2.1. Stool/Fecal Antigen Test (SAT)

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.1. Urea Breath Test (UBT)

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.1. Serology/Antibody/Blood Test

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3. Endoscopic

6.3.1. Culture

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3.2. Histology

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3.3. Rapid Urease/Campylobacter-Like Organism (CLO) Test

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3.1. Polymerase Chain Reaction (PCR)

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7. GLOBAL H. PYLORI TEST MARKET, BY TECHNOLOGY

7.1. Overview

7.2. Immunoassays

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3. Point-of-Care (POC)

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.4. Molecular Diagnostics

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8. GLOBAL H. PYLORI TEST MARKET, BY END USER

8.1. Overview

8.2. Hospitals and Clinics

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.3. Diagnostics Laboratories

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.4. Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9. GLOBAL H. PYLORI TEST MARKET, BY REGION

9.1. Overview

9.2. Americas

9.2.1. North America

9.2.1.1. US

9.2.1.2. Canada

9.2.2. Latin America

9.3. Europe

9.3.1. Western Europe

9.3.1.1. Germany

9.3.1.2. France

9.3.1.3. Italy

9.3.1.4. Spain

9.3.1.5. UK

9.3.1.6. Rest of Western Europe

9.3.2. Eastern Europe

9.4. Asia-Pacific

9.4.1. Japan

9.4.2. China

9.4.3. India

9.4.4. Australia

9.4.5. South Korea

9.4.6. Rest of Asia-Pacific

9.5. Middle East & Africa

9.5.1. Middle East

9.5.2. Africa

10. COMPANY LANDSCAPE

10.1. Overview

10.2. Competitor Dashboard

10.3. Major Growth Strategies in the H. Pylori Test Market

10.4. Competitive Benchmarking

10.5. The Leading Players in terms of Number of Developments in the H. Pylori Test Market

10.6. Key Developments & Growth Strategies

10.7. Major Market Players Financial Matrix & Market Ratio

11. COMPANY PROFILES

11.1. Thermo Fisher Scientific Inc.

11.1.1. Company Overview

11.1.2. Products/Services Offered

11.1.3. Financial Overview

11.1.4. Key Developments

11.1.5. SWOT Analysis

11.1.6. Key Strategies

11.2. Bio-Rad Laboratories, Inc.

11.2.1. Company Overview

11.2.2. Products/Services Offered

11.2.3. Financial Overview

11.2.4. Key Developments

11.2.5. SWOT Analysis

11.2.6. Key Strategies

11.3. F. Hoffmann-La Roche Ltd

11.3.1. Company Overview

11.3.2. Products/Services Offered

11.3.3. Financial Overview

11.3.4. Key Developments

11.3.5. SWOT Analysis

11.3.6. Key Strategies

11.4. Quest Diagnostics Incorporated

11.4.1. Company Overview

11.4.2. Products/Services Offered

11.4.3. Financial Overview

11.4.4. Key Developments

11.4.5. SWOT Analysis

11.4.6. Key Strategies

11.5. Meridian Bioscience

11.5.1. Company Overview

11.5.2. Products/Services Offered

11.5.3. Financial Overview

11.5.4. Key Developments

11.5.5. SWOT Analysis

11.5.6. Key Strategies

11.6. CorisBioconcept SPRL

11.6.1. Company Overview

11.6.2. Products/Services Offered

11.6.3. Financial Overview

11.6.4. Key Developments

11.6.5. SWOT Analysis

11.6.6. Key Strategies

11.7. Cardinal Health

11.7.1. Company Overview

11.7.2. Products/Services Offered

11.7.3. Financial Overview

11.7.4. Key Developments

11.7.5. SWOT Analysis

11.7.6. Key Strategies

11.8. QIAGEN

11.8.1. Company Overview

11.8.2. Products/Services Offered

11.8.3. Financial Overview

11.8.4. Key Developments

11.8.5. SWOT Analysis

11.8.6. Key Strategies

11.9. Abbott Laboratories

11.9.1. Company Overview

11.9.2. Products/Services Offered

11.9.3. Financial Overview

11.9.4. Key Developments

11.9.5. SWOT Analysis

11.9.6. Key Strategies

11.10. Biohit Oyj

11.10.1. Company Overview

11.10.2. Products/Services Offered

11.10.3. Financial Overview

11.10.4. Key Developments

11.10.5. SWOT Analysis

11.10.6. Key Strategies

12. APPENDIX

12.1. References

12.2. Related Reports

LIST OF TABLES

TABLE 1 GLOBAL H. PYLORI TEST MARKET SYNOPSIS, 2020-2027

TABLE 2 GLOBAL H. PYLORI TEST MARKET ESTIMATES & FORECAST, 2020-2027 (USD MILLION)

TABLE 3 GLOBAL H. PYLORI TEST MARKET, BY TEST TYPE, 2020-2027 (USD MILLION)

TABLE 4 GLOBAL H. PYLORI TEST MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)

TABLE 5 GLOBAL H. PYLORI TEST MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 6 GLOBAL H. PYLORI TEST MARKET, BY REGION, 2020-2027 (USD MILLION)

TABLE 7 NORTH AMERICA: H. PYLORI TEST MARKET, BY TEST TYPE, 2020-2027 (USD MILLION)

TABLE 8 NORTH AMERICA: H. PYLORI TEST MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)

TABLE 9 NORTH AMERICA: H. PYLORI TEST MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 10 US: H. PYLORI TEST MARKET, BY TEST TYPE, 2020-2027 (USD MILLION)

TABLE 11 US: H. PYLORI TEST MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)

TABLE 12 US: H. PYLORI TEST MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 13 CANADA: H. PYLORI TEST MARKET, BY TEST TYPE, 2020-2027 (USD MILLION)

TABLE 14 CANADA: H. PYLORI TEST MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)

TABLE 15 CANADA: H. PYLORI TEST MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 16 LATIN AMERICA: H. PYLORI TEST MARKET, BY TEST TYPE, 2020-2027 (USD MILLION)

TABLE 17 LATIN AMERICA: H. PYLORI TEST MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)

TABLE 18 LATIN AMERICA: H. PYLORI TEST MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 19 EUROPE: H. PYLORI TEST MARKET, BY TEST TYPE, 2020-2027 (USD MILLION)

TABLE 20 EUROPE: H. PYLORI TEST MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)

TABLE 21 EUROPE: H. PYLORI TEST MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 22 WESTERN EUROPE: H. PYLORI TEST MARKET, BY TEST TYPE, 2020-2027 (USD MILLION)

TABLE 23 WESTERN EUROPE: H. PYLORI TEST MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)

TABLE 24 WESTERN EUROPE: H. PYLORI TEST MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 25 EASTERN EUROPE: H. PYLORI TEST MARKET, BY TEST TYPE, 2020-2027 (USD MILLION)

TABLE 26 EASTERN EUROPE: H. PYLORI TEST MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)

TABLE 27 EASTERN EUROPE: H. PYLORI TEST MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 28 ASIA-PACIFIC: H. PYLORI TEST MARKET, BY TEST TYPE, 2020-2027 (USD MILLION)

TABLE 29 ASIA-PACIFIC: H. PYLORI TEST MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)

TABLE 30 ASIA-PACIFIC: H. PYLORI TEST MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 31 MIDDLE EAST & AFRICA: H. PYLORI TEST MARKET, BY TEST TYPE, 2020-2027 (USD MILLION)

TABLE 32 MIDDLE EAST & AFRICA: H. PYLORI TEST MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)

TABLE 33 MIDDLE EAST & AFRICA: H. PYLORI TEST MARKET, BY END USER, 2020-2027 (USD MILLION)

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL H. PYLORI TEST MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL H. PYLORI TEST MARKET

FIGURE 4 GLOBAL H. PYLORI TEST MARKET SHARE, BY TEST TYPE, 2020 (%)

FIGURE 5 GLOBAL H. PYLORI TEST MARKET SHARE, BY TECHNOLOGY, 2020 (%)

FIGURE 6 GLOBAL H. PYLORI TEST MARKET SHARE, BY END USER, 2020 (%)

FIGURE 7 GLOBAL H. PYLORI TEST MARKET SHARE, BY REGION, 2020 (%)

FIGURE 8 AMERICAS: H. PYLORI TEST MARKET SHARE BY REGION, 2020 (%)

FIGURE 9 NORTH AMERICA: H. PYLORI TEST MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 10 EUROPE: H. PYLORI TEST MARKET SHARE, BY REGION, 2020 (%)

FIGURE 11 WESTERN EUROPE: H. PYLORI TEST MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 12 ASIA-PACIFIC: H. PYLORI TEST MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 13 MIDDLE EAST & AFRICA: H. PYLORI TEST MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 14 GLOBAL H. PYLORI TEST MARKET: COMPANY SHARE ANALYSIS, 2020 (%)

FIGURE 15 THERMO FISHER SCIENTIFIC INC.: KEY FINANCIALS

FIGURE 16 THERMO FISHER SCIENTIFIC INC.: SEGMENTAL REVENUE

FIGURE 17 THERMO FISHER SCIENTIFIC INC.: REGIONAL REVENUE

FIGURE 18 BIO-RAD LABORATORIES, INC.: KEY FINANCIALS

FIGURE 19 BIO-RAD LABORATORIES, INC.: SEGMENTAL REVENUE

FIGURE 20 BIO-RAD LABORATORIES, INC.: REGIONAL REVENUE

FIGURE 21 F. HOFFMANN-LA ROCHE LTD: KEY FINANCIALS

FIGURE 22 F. HOFFMANN-LA ROCHE LTD: SEGMENTAL REVENUE

FIGURE 23 F. HOFFMANN-LA ROCHE LTD: REGIONAL REVENUE

FIGURE 24 QUEST DIAGNOSTICS INCORPORATED: KEY FINANCIALS

FIGURE 25 QUEST DIAGNOSTICS INCORPORATED: SEGMENTAL REVENUE

FIGURE 26 QUEST DIAGNOSTICS INCORPORATED: REGIONAL REVENUE

FIGURE 27 MERIDIAN BIOSCIENCE: KEY FINANCIALS

FIGURE 28 MERIDIAN BIOSCIENCE: SEGMENTAL REVENUE

FIGURE 29 MERIDIAN BIOSCIENCE: REGIONAL REVENUE

FIGURE 30 CORISBIOCONCEPT SPRL: KEY FINANCIALS

FIGURE 31 CORISBIOCONCEPT SPRL: SEGMENTAL REVENUE

FIGURE 32 CORISBIOCONCEPT SPRL: REGIONAL REVENUE

FIGURE 33 CARDINAL HEALTH: KEY FINANCIALS

FIGURE 34 CARDINAL HEALTH: SEGMENTAL REVENUE

FIGURE 35 CARDINAL HEALTH: REGIONAL REVENUE

FIGURE 36 QIAGEN: KEY FINANCIALS

FIGURE 37 QIAGEN: SEGMENTAL REVENUE

FIGURE 38 QIAGEN: REGIONAL REVENUE

FIGURE 39 ABBOTT LABORATORIES: KEY FINANCIALS

FIGURE 40 ABBOTT LABORATORIES: SEGMENTAL REVENUE

FIGURE 41 ABBOTT LABORATORIES: REGIONAL REVENUE

FIGURE 42 BIOHIT OYJ: KEY FINANCIALS

FIGURE 43 BIOHIT OYJ: SEGMENTAL REVENUE

FIGURE 44 BIOHIT OYJ: REGIONAL REVENUE

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.